Golden Helix, Inc.

🌐🧬 Enterprise Genomic Analysis: Cloud & On-Premise Solutions As genomics continues to scale, organizations need efficient solutions to manage, analyze, and interpret large amounts of complex genomic data. In our latest webcast, we explored how VSWarehouse 3's enterprise-level genomic analysis can be deployed in both cloud and on-premise environments to maximize flexibility, security, and performance. Watch the recording to learn about: ✅ Scalable solutions for enterprise genomics ✅ Cloud vs. on-premise deployment: key considerations ✅ Streamlining genomic workflows for research & clinical use Watch now: https://bit.ly/41u6ygh #EnterpriseGenomics #GenomicData #NGS #NGSAnalysis #PrecisionMedicine

🧬 Next-generation sequencing enables personalized cancer therapy. The ability to identify relevant mutations in cancer allows clinicians to recommend relevant and targeted treatment options. Today, clinicians are moving beyond limited gene panels in order to capture the full spectrum of mutations. 🚀 Our software handles all NGS data types, from short-read and long-read sequencing data, and with the ability to scale from panels to genomes. With our VSClinical AMP tool, users can analyze and find drug matches for all relevant biomarker types as well, thus improving personalized cancer therapy. 🔗 Learn more about VSClinical AMP: https://lnkd.in/gQXtHB8F #NGS #CancerGenomics #PrecisionOncology #ClinicalGenomics #GenomicTesting #MolecularDiagnostics #CancerResearch #VSClinical

The future of genomic data management is here! Join us for an in-depth webcast on VSWarehouse 3, where we’ll explore how our cutting-edge solution is transforming enterprise genomic analysis—whether in the cloud or on-premise. 🔍 What You’ll Learn: ✅ Scalable data storage & management ✅ Streamlined variant analysis workflows ✅ Secure deployment options tailored to your needs Whether you're a clinical researcher, bioinformatician, or part of a precision medicine team, this webcast is designed to help you unlock the full potential of genomic data at scale. Don't miss out! #Genomics #Bioinformatics #PrecisionMedicine #CloudComputing #EnterpriseGenomics #GoldenHelix #NGS #NextGenerationSequencing

🧬 CYP2D6 plays a crucial role in the world of pharmacogenomics. CYP2D6 genetic variations can affect drug metabolism and response, as well as influence drug efficacy and toxicity. 💡That is why we have created a specialized CYP2D6 star allele caller "CypCall." It identifies star alleles in CYP2D6, which can be especially challenging due to the gene's homologous pseudogene CYP2D7. We developed CypCall to enhance pharmacogenomic analysis and give clinicians the ability to tailor drug therapies based on an individual's genetic profile. To learn more, visit us here: https://lnkd.in/gxrFRWR9  #PGx #VarSeq #VSPGx #Pharmacogenomics #CYP2D6 #StarAllele

Discover how VSWarehouse 3.0 is transforming genomic analysis in clinical labs! This webcast dives into real-world user experiences, showcasing how its cloud capabilities streamline cancer and germline workflows, ensure data compliance, and offer cost-effective scaling solutions. Don't miss out on insights into building robust bioinformatics pipelines with nimble scheduling and API integrations. 🎥 Watch on-demand and elevate your lab's genomic testing capabilities: https://bit.ly/3Q1hlbr #Genomics #Bioinformatics #CloudComputing #ClinicalGenomics #CancerResearch #GermlineAnalysis #DataCompliance #VSWarehouse #PrecisionMedicine

📝 CADD 1.7 has been added as an annotation track in VarSeq. This latest release of CADD incorporates new annotations into its model, resulting in significant improvements in variant scoring. 🧬 Incorporating these annotation tracks into the VarSeq annotation library gives users a powerful tool for variant prioritization and enhancing their rare disease workflows. This update is particularly valuable for identifying potentially clinically relevant non-coding variants, which can often be overlooked in traditional analyses. To learn more about VarSeq and the newly integrated CADD 1.7, visit us here: https://bit.ly/42H5Xsu #RareDisease #Genetics #CADD #VariantAnnotation #NGSAnalysis #PrecisionMedicine

🩸 Our blood combined with NGS is a powerful diagnostic tool that can help detect cancer biomarkers, identify the cancer stage, and monitor cancer treatments. Roughly 10% of the population is diagnosed with blood cancers such as leukemias, lymphomas, and myelomas per year. Up-to-date information from reliable cancer resources paired with high-quality somatic variant detection helps medical centers and oncologists diagnose, manage, and treat these complex hematological cancers. 💡 We recently launched Golden Helix CancerKB 4.0, which we have titled "The Hematological Release." In this release, our curation team leveraged the NCCN Guidelines, WHO guidelines, and ICC for prognostic and diagnostic interpretation creation-focused first on blood cancers. Streamline your treatment decisions and automate your somatic analysis with CancerKB 4.0, paired with VSClinical: https://lnkd.in/g4W4-uQd #BloodCancer #Hematology #CancerCenters #SomaticAnalysis #PrecisionMedicine #CancerKB #NGS #CancerTreatment

🧬 Scaling genomic analysis without skyrocketing costs or compromising data security can be a significant challenge for clinical labs. From massive data volumes to stringent compliance requirements, traditional infrastructures often struggle to keep pace. Addressing these hurdles head-on, VSWarehouse 3.0’s new cloud capabilities empower labs with on-demand scalability, flexible hybrid deployments, and cost-effective solutions— all while maintaining data sovereignty and security. 🖥️ Want to learn more? Register for our upcoming webcast to see how users can transform their workflows using VSWarehouse 3.0! #GenomicAnalysis #ClinicalLabs #Scalability #CloudComputing #Bioinformatics #PrecisionMedicine #DataSecurity #Compliance #HealthcareIT #HybridCloud

💊 We recognize that adverse drug reactions, or ADRs, can significantly impact healthcare systems and patient outcomes. That is why pharmacogenomics is continuing to play a pivotal role in advancing precision medicine. Pharmacogenomics leverages genetic insights, allowing labs and clinicians to tailor medications and prescriptions to each patient’s unique profile, mitigating the risks associated with ADRs. 💥 Want to see how VSPGx can empower your lab to offer more actionable clinical insights and reduce ADRs? Visit our site to learn more: https://lnkd.in/gkTBqxqj #Pharmacogenomics #Pharmacogenetics #PrecisionMedicine #GoldenHelix #VSPGx #HealthcareInnovation #ADRs #AdverseDrugReactions

We’ve just wrapped up a dynamic 2024, reaching key milestones. To learn more about what we have in store for 2025, visit our blog, where our President and CEO, Dr. Andreas Scherer, has charted out our 2025 Strategy! #GoldenHelix #ClinicalGenetics #PersonalizedMedicine #Somatic #Pharmacogenetics #BringYourOwnCloud #NextGenSequencing